An update from Alpha Tau Medical Ltd ( (DRTS)) is now available. On January 5, 2026, Alpha Tau Medical announced it has submitted the first module of its pre-market approval application to the U.S.
In her early 30s, Bonnie began to experience frequent shortness of breath. Though she was still active, she noticed that everyday tasks like exercising, climbing stairs and dancing left her breathless ...
Alpha Tau Medical Ltd (DRTS) announced an update on their ongoing clinical study. Alpha Tau Medical Ltd (DRTS) has recently completed a clinical study titled ‘A Feasibility of Neoadjuvant Interstitial ...
Carin Leong: What if people with type 1 diabetes could start making their own insulin? Scientists have just taken a big step in that direction. They treated a patient with 80 million lab-made ...
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care ...
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
Reston, VA (December 4, 2025)--A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a ...
About a quarter of U.S. service members and veterans who start psychotherapy for post-traumatic stress disorder (PTSD) quit before they finish treatment, according to a recent study, with experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results